aTyr Pharma Inc (NASDAQ:LIFE)

2.80
Delayed Data
As of May 26
 0.00 / 0.00%
Today’s Change
2.68
Today|||52-Week Range
13.10
-62.52%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for aTyr Pharma Inc have a median target of 20.00, with a high estimate of 21.00 and a low estimate of 11.00. The median estimate represents a +614.29% increase from the last price of 2.80.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in aTyr Pharma Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.39
Sales
$2.0M
Reporting Date
Aug 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 10.61%
 
 
 
 
 
 
Growthannually 1.04%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.